Serum metabolomic identifies new diagnostic biomarkers for AFP-negative hepatocellular carcinoma

被引：0
|
作者：
Bian, S. [1 ]
Jia, X. [1 ]
Zhang, S. [1 ]
Song, P. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.annonc.2023.04.199
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-143
引用
收藏
页码：S65 / S66
页数：2
相关论文
共 50 条
  • [31] Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study
    Wang, Lei
    Peng, Jin-Lin
    Wu, Ji-Zhou
    MEDICINE, 2023, 102 (13) : E33319
  • [32] Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing AFP-negative hepatocellular carcinoma
    Li, Qing
    Liu, Haiyan
    Wang, Han
    Xiong, Wenzhuo
    Dai, Liping
    Zhang, Xiuzhi
    Wang, Peng
    Ye, Hua
    Shi, Jianxiang
    Fang, Zhihao
    Wang, Keyan
    PEERJ, 2024, 12
  • [33] Diagnosis of AFP-negative Early-stage Hepatocellular Carcinoma Using Fuc-PON1
    Shu, Hong
    Li, Wei
    Shang, Shuxin
    Qin, Xue
    Zhang, Shu
    Liu, Yinkun
    DISCOVERY MEDICINE, 2017, 23 (126) : 163 - 168
  • [34] Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver
    Wang, Peihua
    Nie, Fang
    Dong, Tiantian
    Yang, Dan
    Liu, Ting
    Wang, Guojuan
    DIAGNOSTICS, 2021, 11 (12)
  • [35] SERUM AFP AS A DIAGNOSTIC MARKER OF HEPATOCELLULAR CARCINOMA IN LIRADS M LESIONS
    Nedrudi, Marybeth
    Wolfson, Tanya
    Ludwig, Daniel
    Fraum, Tyler
    Chernyak, Victoria
    Kierans, Andrea Siobhan
    Burke, Lauren M.
    McGinty, Katrina A.
    Ha, Hong-Il
    Mendiratta-Lala, Mishal
    Ranathunga, Damithri
    McInnes, Matthew
    Makkar, Jasnit S.
    Fowler, Kathryn
    Oloruntoba, Omobonike
    Gamst, Anthony
    Cardona, Diana M.
    Muir, Andrew Joseph
    Bashir, Mustafa
    HEPATOLOGY, 2020, 72 : 684A - 685A
  • [36] Novel Prognostic Scores Based on Plasma Prothrombin Time and Fibrinogen Levels in Patients With AFP-Negative Hepatocellular Carcinoma
    Mao, Minjie
    Wang, Xueping
    Song, Yiling
    Sheng, Hui
    Han, Runkun
    Lin, Weihong
    Dai, Shuqin
    CANCER CONTROL, 2020, 27 (01)
  • [37] Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS
    He, X.
    Wang, Y.
    Zhang, W.
    Li, H.
    Luo, R.
    Zhou, Y.
    Li, C.
    Liao, M.
    Huang, H.
    Lv, X.
    Xie, Z.
    He, M.
    NEOPLASMA, 2014, 61 (01) : 17 - 26
  • [38] Aptamers against the serum of AFP-negative hepatoma: Selection, diagnostic evaluation, and target protein capture and proteomic analysis
    Wang, Ting
    Zhang, Kun-He
    Hu, Piao-Ping
    Wan, Qin-Si
    Huang, Zeng-Yong
    Zhang, Pan
    Huang, De-Qiang
    Lv, Nong-Hua
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 189 - 189
  • [39] Serum AFU, 5'-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
    Zhu Junna
    Chen Gongde
    Xu Jinying
    Zhou Xiu
    OPEN MEDICINE, 2017, 12 (01): : 354 - 358
  • [40] Integrative plasma proteomics identifies novel diagnostic biomarkers in hepatocellular carcinoma
    Zhou, Shuang
    Abe, Yuichi
    Isomura, Hisanori
    Ishigami, Masatoshi
    Fujishiro, Mitsuhiro
    Taguchi, Ayumu
    CANCER SCIENCE, 2023, 114 : 58 - 58
12345